Dublin, Aug. 22, 2017 -- The "United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to Research and Markets' offering.
The potential market of proton therapy in United States would be more than US$ 15 Billion by the end of 2021 and it is expected to grow with a CAGR of 6.04 percent in future.
At present the United States holds world's 40 percent of Proton Beam Therapy Facility. In recent time, more research institutes and hospitals are investing in proton therapy to make the technology more accessible to patients.
In this report we have studied the market in two parts: a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.
a) Actual Market is the current market which is already present
b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
United States Proton Therapy Market has been analyzed from four view points:
- United States Proton Therapy Actual Market & Forecast (2009 - 2021)
- United States Proton Therapy Untapped Market & Forecast (2009 - 2021)
- United States Proton Therapy Treated Patient Volume & Forecast (2009 - 2021)
- United States Proton Therapy Untapped Patient Volume & Forecast (2009 - 2021)
Key Topics Covered:
1. Executive Summary
2. United States Proton Therapy Market - Actual & Potential Market
2.1 United States - Proton Therapy Market
2.2 United States - Potential Proton Therapy Market & Forecast
3. United States Proton Therapy Patient Number - Actual and Potential
3.1 United States - Patients Treated with Proton Therapy Actual Numbers & Forecast
3.2 United States - Patients with Proton Therapy Potential Numbers & Forecast
4. United States - List of Proton Therapy Centers
5. United States - Proton Therapy Treated Patients by Centers
5.1 Loma Linda (LLUMC) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
5.2 UCSF - CNL Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.3 Boston (NPTC) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.4 Bloomington (MPRI, 2) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
5.5 Houston (MD Anderson) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.6 UFPTI Jacksonville Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.7 Oklahoma City (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2009 - 2015)
5.8 CDH Warrenville Proton Therapy Center - Number of Patients Treated (2010 - 2015)
5.9 Philadelphia (Upenn) Proton Therapy Center - Number of Patients Treated (2011 - 2015)
5.10 Hampton (HUPTI) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
5.11 New Jersey (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
5.12 Seattle (SCCA ProCure PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
5.13 St. Louis (S. Lee King PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
5.14 Provision Center for Proton Therapy, Knoxville, TN - Number of Patients Treated (2014 - 2015)
5.15 San Diego (Scripps PTC) - Number of Patients Treated (2014 - 2015)
5.16 Shreveport (Willis Knighton) Proton Therapy Center - Number of Patients Treated (2014 - 2015)
5.17 Jacksonville (Ackerman CC) Proton Therapy Center - Number of Patients Treated (2015)
5.18 Rochester (Mayo PBTC) Proton Therapy Center - Number of Patients Treated (2015)
5.19 Brunswick (Laurie PC) Proton Therapy Center - Number of Patients Treated (2015)
5.20 Irving (Texas Center for PT) Proton Therapy Center - Number of Patients Treated (2015)
5.21 Memphis (St. Jude PTC) Proton Therapy Center - Number of Patients Treated (2015)
6. Proton Therapy - Reimbursement Policies
6.1 Proton Therapy Reimbursement Policies for Patients
6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
7. Components of a Standard Proton Therapy Center
7.1 Proton Accelerator
7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
7.1.2 Cyclotrons (example: MGH Boston)
7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
7.1.4 Linacs (Rome)
7.1.5 H-minus Synchrotrons
7.1.6 Separated Sector Cyclotrons
7.1.7 Super-conducting Cyclotrons
7.1.8 Fast Cycling Synchrotron
7.2 Beam Transport System
7.3 Beam Delivery System
7.3.1 The Passive Scattering Technique
7.3.2 Beam Scanning
7.4 Nozzle
7.4.1 Single Scattering
7.4.2 Double Scattering
7.4.3 Uniform Scanning Nozzle
7.4.4 Pencil Scanning Nozzle
7.5 Treatment Planning System
7.6 Image Viewers
7.7 Patient Positioning System (PPS)
7.8 Human Resource
8. Global Proton Therapy - Company Analysis (2010-2021)
8.1 IBA Proton Therapy
8.1.1 Sales Analysis
8.2 Varian Medical Systems
8.2.1 Sales Analysis
8.3 Elekta
8.3.1 Sales Analysis
9. Proton Therapy - Driving Factors
9.1 Technology Advancement
9.2 Growing Incidence of Cancer Patients in United States
10. Proton Therapy - Challenges
10.1 Requires Huge Investment
10.2 Operations Challenges
Companies Mentioned
- Elekta
- IBA
- Varian Medical Systems
Proton Therapy Centers:
- Bloomington (MPRI, 2)
- Boston (NPTC)
- Brunswick (Laurie PC)
- CDH Warrenville
- Hampton (HUPTI)
- Houston (MD Anderson)
- Irving (Texas Center for PT)
- Jacksonville (Ackerman CC)
- Loma Linda (LLUMC)
- Memphis (St. Jude PTC)
- New Jersey (ProCure PTC)
- Oklahoma City (ProCure PTC)
- Philadelphia (Upenn)
- Provision Center for Proton Therapy, Knoxville, TN
- Rochester (Mayo PBTC)
- San Diego (Scripps PTC)
- Seattle (SCCA ProCure PTC)
- Shreveport (Willis Knighton)
- St. Louis (S. Lee King PTC)
- UCSF - CNL
- UFPTI Jacksonville
For more information about this report visit https://www.researchandmarkets.com/research/7d8bt5/united_states
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Nuclear Medicine and Radiopharmacology


OpenAI Explores Massive Funding Round at $750 Billion Valuation
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 



